| Name | Title | Contact Details |
|---|
health first medical center pc is a Dunbar, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DCI International is a Newberg, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.
"SensiVida Medical Technologies, Inc. is a minimally invasive Diagnostic Device company. Our patented Microsystems-based optical technology automates bio-sensing and data acquisition while minimizing patient discomfort. Our ""platform"" technology can be applied to a number of disease state diagnostics, including allergy testing, pain-free automated glucose monitoring and blood coagulation testing (e.g. for Coumadin patients), TB testing, and cholesterol monitoring."
Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company`s mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system. ACT`s technology is the only system in the world to leverage feedback from four unique capabilities: temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing. The ACT system is not currently approved for commercial use.